Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ishares Genomics Immunology and Healthcare ETF (IDNA)

Ishares Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 328,941,000
  • Shares Outstanding, K 6,550
  • 60-Month Beta 0.78
Trade IDNA with:
  • Price/Earnings ttm 27.74
  • Annual Dividend & Yield 0.09 (0.18%)
  • Most Recent Dividend 0.052 on 06/10/21
  • Management Fee 0.47%
  • Sectors:

Options Overview

Details
  • Implied Volatility 24.60%
  • Historical Volatility 21.31%
  • IV Percentile 10%
  • IV Rank 13.68%
  • IV High 98.42% on 11/09/20
  • IV Low 12.91% on 03/22/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 153
  • Open Int (30-Day) 151

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.38 +7.81%
on 07/27/21
51.67 -1.14%
on 07/06/21
-0.93 (-1.79%)
since 07/02/21
3-Month
42.50 +20.19%
on 05/11/21
53.00 -3.62%
on 06/30/21
+3.47 (+7.29%)
since 05/03/21
52-Week
34.32 +48.84%
on 09/04/20
55.03 -7.18%
on 02/10/21
+12.15 (+31.21%)
since 08/03/20

Most Recent Stories

More News
A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAM : 92.31 (+1.89%)
EDIT : 42.11 (+1.37%)
PBE : 76.18 (+0.95%)
NTLA : 138.79 (+1.63%)
CRSP : 121.42 (-0.75%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)
Moderna ETFs to Rise on Positive COVID-19 Vaccine Updates

Moderna has once again come up with interesting updates about its COVID-19 vaccine.

AZN : 57.66 (+0.49%)
PFE : 45.68 (+3.91%)
MRNA : 386.51 (+11.51%)
IBB : 169.40 (+2.14%)
BBH : 211.75 (+2.03%)
IDNA : 51.08 (+1.63%)
GERM : 42.60 (+2.80%)
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGN : 586.51 (+1.63%)
BEAM : 92.31 (+1.89%)
EDIT : 42.11 (+1.37%)
NTLA : 138.79 (+1.63%)
CRSP : 121.42 (-0.75%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)
ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens

Moderna (MRNA) is once again in the spotlight with an impressive update relating to mRNA-1273.

MRNA : 386.51 (+11.51%)
IBB : 169.40 (+2.14%)
BBH : 211.75 (+2.03%)
IDNA : 51.08 (+1.63%)
GERM : 42.60 (+2.80%)
Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

XBI : 124.82 (+0.72%)
BTEC : 55.55 (-0.43%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)
Moderna ETFs to Shine on Vaccine News as Outbreak Worsens

Positive coronavirus vaccine progress from Moderna (MRNA) has hogged investors' attention.

IBB : 169.40 (+2.14%)
XBI : 124.82 (+0.72%)
BBH : 211.75 (+2.03%)
BTEC : 55.55 (-0.43%)
IDNA : 51.08 (+1.63%)
GERM : 42.60 (+2.80%)
ETFs in Focus on Bayer's Bet on Gene Therapy

Bayer has made a big bet on gene therapy by announcing the acquisition of U.S. biotech firm Asklepios BioPharmaceutical for as much as $4 billion.

PBE : 76.18 (+0.95%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 169.40 (+2.14%)
XBI : 124.82 (+0.72%)
BBH : 211.75 (+2.03%)
BTEC : 55.55 (-0.43%)
IDNA : 51.08 (+1.63%)
GERM : 42.60 (+2.80%)
Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

REGN : 586.51 (+1.63%)
GILD : 69.83 (+2.17%)
NVTA : 28.50 (+0.74%)
CRSP : 121.42 (-0.75%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)
Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBE : 76.18 (+0.95%)
ARKG : 84.79 (+0.39%)
GNOM : 23.01 (+0.74%)
IDNA : 51.08 (+1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Key Turning Points

3rd Resistance Point 52.60
2nd Resistance Point 51.85
1st Resistance Point 51.47
Last Price 51.08
1st Support Level 50.34
2nd Support Level 49.59
3rd Support Level 49.21

See More

52-Week High 55.03
Last Price 51.08
Fibonacci 61.8% 47.12
Fibonacci 50% 44.67
Fibonacci 38.2% 42.23
52-Week Low 34.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar